Rearrangement of the p53 gene in human osteogenic sarcomas.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  1987-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/PNAS.84.21.7716PMID 2823272PMCID PMC299371
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human p53 gene localized to short arm of chromosome 17

  1986cited by this paper
• Characterization of the human p53 gene

  1986cited by this paper
• Molecular cloning and in vitro expression of a cDNA clone for human cellular tumor antigen p53

  1985cited by this paper
• The 5′ region of the p53 gene: evolutionary conservation and evidence for a negative regulatory element.

  1985cited by this paper
• p53 cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos, and tumors

  1985cited by this paper
• Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation

  1984cited by this paper
• Reconstitution of p53 expression in a nonproducer Ab-MuLV-transformed cell line by transfection of a functional p53 gene.

  1984cited by this paper
• Growth regulation of a cellular tumour antigen, p53, in nontransformed cells

  1984cited by this paper
• Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53

  1984cited by this paper
• Role of the p53 protein in cell proliferation as studied by microinjection of monoclonal antibodies

  1984cited by this paper
• Participation of p53 cellular tumour antigen in transformation of normal embryonic cells

  1984cited by this paper
• The 53,000-dalton cellular protein and its role in transformation.

  1983cited by this paper
• Transcriptional activation of an unrearranged and untranslocated c-myc oncogene by translocation of a C lambda locus in Burkitt.

  1983cited by this paper
• Altered nucleotide sequences of a translocated c-myc gene in Burkitt lymphoma

  1983cited by this paper
• Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells.

  1982cited by this paper
• Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells

  1981cited by this paper
• p53 transformation-related protein: detection by monoclonal antibody in mouse and human cells.

  1981cited by this paper
• Detection of a common feature in several human tumor cell lines--a 53,000-dalton protein.

  1981cited by this paper
• The SV40 A gene product is required for the production of a 54,000 MW cellular tumor antigen.

  1979cited by this paper
• T antigen is bound to a host protein in SY40-transformed cells

  1979cited by this paper

• Ongoing chromothripsis underpins osteosarcoma genome complexity and clonal evolution.

  2025cites this paper
• Repurposing riluzole as an anti-osteosarcoma agent

  2025cites this paper
• Non-Coding RNAs in Diagnostic Pathology of High-Grade Central Osteosarcoma

  2025cites this paper
• Untangling the Role of MYC in Sarcomas and Its Potential as a Promising Therapeutic Target

  2025cites this paper
• The Nrf2 Inhibitor Brusatol Promotes Human Osteosarcoma (MG63) Growth and Blocks EB1089-Induced Differentiation

  2025cites this paper
• A trend of osteocalcin in diabetes mellitus research: bibliometric and visualization analysis

  2025cites this paper
• The importance of TP53 status in cancer therapy: The example of chronic lymphocytic leukemia

  2025cites this paper
• Transcriptomic profiles of myxofibrosarcoma and undifferentiated pleomorphic sarcoma correlate with clinical and genomic features

  2024cites this paper
• Treating Head and Neck Cancer in the Age of Immunotherapy: A 2023 Update

  2023cites this paper
• Gossypetin Is a Novel Modulator of Inflammatory Cytokine Production and a Suppressor of Osteosarcoma Cell Growth

  2023cites this paper
• Comprehensive analysis of immune implication and prognostic value of DHX33 in sarcoma

  2023cites this paper
• Disruption of the TP53 locus in osteosarcoma leads to TP53 promoter gene fusions and restoration of parts of the TP53 signalling pathway

  2023cites this paper
• Dysregulated gene expression through TP53 promoter swapping in osteosarcoma

  2023cites this paper
• A comprehensive study of p53 protein

  2022cites this paper
• Multi-Omic Analysis of Two Common P53 Mutations: Proteins Regulated by Mutated P53 as Potential Targets for Immunotherapy

  2022cites this paper
• Integral Analyses of Competing Endogenous RNA Mechanisms and DNA Methylation Reveal Regulatory Mechanisms in Osteosarcoma

  2021cites this paper
• MEK inhibition preferentially suppresses anchorage‐independent growth in osteosarcoma cells and decreases tumors in vivo

  2021cites this paper
• Mutant p53 Gain-of-Function: Role in Cancer Development, Progression, and Therapeutic Approaches

  2021cites this paper
• Genetic drivers and cells of origin in sarcomagenesis

  2021cites this paper
• Translational cell biology of highly malignant osteosarcoma

  2021cites this paper
• Osteoidbildende Knochentumoren

  2020cites this paper
• Oncogenes hijack a constitutively activeTP53promoter in osteosarcoma

  2020cites this paper
• Molecular Biology of Osteosarcoma

  2020cites this paper
• Genomic and Transcriptomic Analyses of Osteogenic Tumours of Bone

  2020cites this paper
• Genomic Complexity of Osteosarcoma and Its Implication for Preclinical and Clinical Targeted Therapies.

  2020cites this paper
• Sarcomas of Bone

  2020cites this paper
• LncRNA LINC00588 Suppresses the Progression of Osteosarcoma by Acting as a ceRNA for miRNA-1972

  2020cites this paper
• Emerging next-generation sequencing-based discoveries for targeted osteosarcoma therapy.

  2020cites this paper
• TP53 structural variants in metastatic prostatic carcinoma

  2019cites this paper
• Analysis of TP53 gene in uterine myomas: No mutations but P72R polymorphism is associated with myoma development

  2019cites this paper
• TP53 in bone and soft tissue sarcomas.

  2019cites this paper
• Immunohistochemical Expression of p53 and Bcl-2 in Algerian Cervical Carcinoma

  2018cites this paper
• Simvastatin exerts anticancer effects in osteosarcoma cell lines via geranylgeranylation and c-Jun activation.

  2018cites this paper
• Combination of etoposide and fisetin results in anti-cancer efficiency against osteosarcoma cell models

  2018cites this paper
• Molecular Subgroups of Glioblastoma– an Assessment by Immunohistochemical Markers

  2017cites this paper
• Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice.

  2017cites this paper
• Cytokine, Chemokine, and Growth Factor Profile Characterization of Undifferentiated and Osteoinduced Human Adipose-Derived Stem Cells

  2017cites this paper
• Osteoblasts activate the Nrf2 signalling pathway in response to arsenic trioxide treatment.

  2016cites this paper
• Investigating the Roles of Zinc-Binding Protein (ZBP-89) and Rela (NFkB-p65) in the Regulation of Matrix Metalloproteinase 1 (MMP1) Gene Expression

  2016cites this paper
• Aggregation and Prion-Like Properties of Misfolded Tumor Suppressors: Is Cancer a Prion Disease?

  2016cites this paper
• Genetics of Osteosarcoma

  2016cites this paper
• The General Information of the Tumor Suppressor Gene p53 and the Protein p53

  2015cites this paper
• Structure-Related Mode-of-Action Differences of Anticancer Organoruthenium Complexes with β-Diketonates.

  2015cites this paper
• Oncogenomic screening strategies to identify driver genes in acute myeloid leukaemia

  2015cites this paper
• TP53 intron 1 hotspot rearrangements are specific to sporadic osteosarcoma and can cause Li-Fraumeni syndrome

  2015cites this paper
• Osteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate Therapies.

  2015cites this paper
• TP 53 intron 1 hotspot rearrangements are specific to sporadic osteosarcoma and can cause Li-Fraumeni syndrome

  2015cites this paper
• Misfolding, Aggregation, and Disordered Segments in c-Abl and p53 in Human Cancer

  2015cites this paper
• p31comet-Induced Cell Death Is Mediated by Binding and Inactivation of Mad2

  2015cites this paper
• Differentiation of osteoblasts to osteocytes in 3D type I collagen gels - a novel tool to study osteocyte responses to mechanical loading

  2015cites this paper
• P44, the ‘longevity-assurance’ isoform of P53, regulates tau phosphorylation and is activated in an age-dependent fashion

  2014influential citation
• TP53 Mutations in Human Cancer: Database Reassessment and Prospects for the Next Decade

  2014cites this paper
• The Tumor Suppressor p53

  2014cites this paper
• Modulation of insulin/IGFs pathways by sirtuin-7 inhibition in drug-induced chemoreistance

  2014cites this paper
• Recommendations for Analyzing and Reporting TP53 Gene Variants in the High‐Throughput Sequencing Era

  2014cites this paper
• Cadmium-induced genotoxicity in human osteoblast-like cells.

  2014cites this paper
• Extra-skeletal Osteosarcoma Presenting as a Peri-ampullary Mass

  2014cites this paper
• Mutant p53 gain of function can be at the root of dedifferentiation of human osteosarcoma MG63 cells into 3AB-OS cancer stem cells.

  2014cites this paper
• Prognostic value of p53 alterations in human osteosarcoma: a meta analysis.

  2014cites this paper
• Identification and characterization of a novel potential transcription factor involved in osteogenic differentiation of mesenchymal stem cells.

  2014cites this paper
• The regulation of p53-dependent microRNA expression in response to genotoxic stress

  2014cites this paper
• Human osteoblast growth and maturation in response to metformin and the thienopyridone, A769662

  2014cites this paper
• Induction of Stress Induced Premature Senescence by Sirtuin-7 Inhibition: A Novel Mechanism for Multi Drug Resistance

  2013influential citation
• Morphological Modifications in Sarcoma- A Brief Description on SarcomaBiology

  2013cites this paper
• Overexpression of TTRAP inhibits cell growth and induces apoptosis in osteosarcoma cells

  2013cites this paper
• TP53 Mutations and Chemotherapy Response to Neoadjuvant Metotrexate, Cisplatin and Adryamicin Chemotherapy in Resected Osteosarcoma

  2013cites this paper
• Tumor Protein p53 (TP53) Testing and Li-Fraumeni Syndrome

  2013cites this paper
• Role of Leptomycin in p53 Induced Apoptosis

  2013cites this paper
• The human oncoprotein MDM2 induces replication stress eliciting early intra-S-phase checkpoint response and inhibition of DNA replication origin firing

  2013cites this paper
• A Cell-Permeable Fusion Protein Based on Clostridium botulinum C2 Toxin for Delivery of p53 Tumorsuppressor into Cancer Cells

  2013cites this paper
• Mitotic catastrophe triggered in human cancer cells by the viral protein apoptin

  2013cites this paper
• Adenocarcinoma of the cervix uteri : methods to improve diagnostics: biological markers and HPV testing

  2013cites this paper
• In search of an osteoblast cell model for in vitro research.

  2012cites this paper
• The Genetics of Osteosarcoma

  2012cites this paper
• Wip1 promotes RUNX2-dependent apoptosis in p53-negative tumors and protects normal tissues during treatment with anticancer agents

  2011cites this paper
• The Cyclin-Dependent Kinase Inhibitor SCH 727965 (Dinacliclib) Induces the Apoptosis of Osteosarcoma Cells

  2011cites this paper
• MDM2 antagonist Nutlin-3a potentiates antitumour activity of cytotoxic drugs in sarcoma cell lines

  2011cites this paper
• Physical and Functional Antagonism between Tumor Suppressor Protein p53 and Fortilin, an Anti-apoptotic Protein*

  2011cites this paper
• The novel metastasis promoter Merm1/Wbscr22 enhances tumor cell survival in the vasculature by suppressing Zac1/p53-dependent apoptosis.

  2011cites this paper
• Tumor and Stem Cell Biology The Novel Metastasis Promoter Merm 1 / Wbscr 22 Enhances Tumor Cell Survival in the Vasculature by Suppressing Zac 1 / p 53-Dependent Apoptosis

  2011cites this paper
• Selective Cytotoxicity against Human Osteosarcoma Cells by a Novel Synthetic C-1 Analogue of 7-Deoxypancratistatin Is Potentiated by Curcumin

  2011cites this paper
• A Novel Assay for the Quantification of Active Transcription Factors

  2011cites this paper
• Molecular and genetic basis of childhood cancer

  2011cites this paper
• Animal Models of Malignant Primary Bone Tumors and Novel Therapeutic Approaches

  2010cites this paper
• Nm23-H1 can induce cell cycle arrest and apoptosis in B cells

  2010cites this paper
• Genetics of Osteosarcoma

  2010cites this paper
• p53 is balancing development, differentiation and de-differentiation to assure cancer prevention.

  2010cites this paper
• The history of p53

  2010cites this paper
• The expression and significance of IDH1 and p53 in osteosarcoma

  2010cites this paper
• Nuclear lamins: key regulators of nuclear structure and activities

  2009cites this paper
• Molecular Basis of Human Malignancy

  2009cites this paper
• Human Cytomegalovirus IE 172 Protein Interacts with p 53 and Inhibits p 53-Dependent Transactivation by a Mechanism Different from That of IE 2-86 Protein

  2009cites this paper
• Human Cytomegalovirus IE1-72 Protein Interacts with p53 and Inhibits p53-Dependent Transactivation by a Mechanism Different from That of IE2-86 Protein

  2009cites this paper
• CHAPERONE EXPRESSION AND EFFECTS OF ITS INHIBITION ON BREAST CANCER SENSITIZATION

  2009cites this paper
• 2. of Osteosarcoma

  2009cites this paper
• Genetics and Molecular Biology of Bone and Soft Tissue Tumors

  2009cites this paper
• The expression of p53 antigen in primary malignant epithelial tumors of the liver: an immunohistochemical study.

  2008cites this paper
• Editorial Comment: Cancer Biology – Lessons Learned From Sarcoma

  2008cites this paper
• Establishment and characterization of OS 99-1, a cell line derived from a highly aggressive primary human osteosarcoma

  2008cites this paper
• Visualizing loss of heterozygosity in living mouse cells and tissues.

  2008cites this paper